Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Silmitasertib by Senhwa Biosciences for Basal Cell Carcinoma (Basal Cell Epithelioma): Likelihood of Approval
Silmitasertib is under clinical development by Senhwa Biosciences and currently in Phase I for Basal Cell Carcinoma (Basal Cell Epithelioma)....